aminoglutethimide and fluoxymesterone

aminoglutethimide has been researched along with fluoxymesterone in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19907 (77.78)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, K1
Andersen, J; Poulsen, HS1
Bartholomew, M; Boucher, A; Caplan, R; Gordon, R; Harvey, H; Lipton, A; Manni, A; Santen, R; Simmonds, M; White-Hershey, D1
Boucher, AE; Drago, J; Gordon, RA; Harvey, H; Lipton, A; Manni, A; Rohner, TJ; Santen, RJ; Simmonds, M; White-Hershey, D1
Kamby, C; Rose, C1
Gennatas, CS; Kalovidouris, A; Kouvaris, J; Papavasiliou, C; Paraskevas, GA; Trichopoulos, D1
Boucher, AE; Drago, J; Gordon, R; Harvey, H; Lipton, A; Manni, A; Rohner, T; Santen, RJ; Simmonds, M; Wettlaufer, J1
Bezwoda, WR; Browde, S; Derman, DP; Goss, G; Lange, M1
Andersen, J; Andersson, M; Bastholt, L; Christensen, IJ; Dombernowsky, P; Kamby, C; Mouridsen, HT; Munkholm, P; Møller, KA; Rose, C1

Reviews

1 review(s) available for aminoglutethimide and fluoxymesterone

ArticleYear
[Hormone therapy of neoplasms].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Mar-10, Volume: 80, Issue:3

    Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen

1991

Trials

6 trial(s) available for aminoglutethimide and fluoxymesterone

ArticleYear
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:9

    Topics: Acid Phosphatase; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Hydrocortisone; Male; Prostatic Neoplasms; Random Allocation; Testosterone; Time Factors

1988
Androgen priming and response to chemotherapy in advanced prostatic cancer.
    The Journal of urology, 1986, Volume: 136, Issue:6

    Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Fluoxymesterone; Humans; Hydrocortisone; Male; Middle Aged; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation

1986
Metastatic pattern and response to endocrine therapy in human breast cancer.
    Breast cancer research and treatment, 1986, Volume: 8, Issue:3

    Topics: Aminoglutethimide; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Medroxyprogesterone; Menopause; Neoplasm Metastasis; Tamoxifen

1986
A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1987, Volume: 9, Issue:3

    Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Fluoxymesterone; Humans; Hydrocortisone; Middle Aged; Random Allocation; Tamoxifen

1987
Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer.
    Journal of steroid biochemistry, 1987, Volume: 27, Issue:1-3

    Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Fluorouracil; Fluoxymesterone; Humans; Hydrocortisone; Male; Methotrexate; Orchiectomy; Prostatic Neoplasms; Random Allocation; Spinal Cord Compression

1987
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
    Breast cancer research and treatment, 2000, Volume: 61, Issue:2

    Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Drug Synergism; Enzyme Inhibitors; Female; Fluoxymesterone; Humans; Hydrocortisone; Life Tables; Neoplasm Metastasis; Neoplasm Proteins; Salvage Therapy; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Treatment Outcome

2000

Other Studies

2 other study(ies) available for aminoglutethimide and fluoxymesterone

ArticleYear
Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer.
    Cancer, 1989, Nov-01, Volume: 64, Issue:9

    Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Immunohistochemistry; Menopause; Middle Aged; Neoplasm Recurrence, Local; Paraffin; Receptors, Estrogen; Survival Analysis; Tamoxifen

1989
Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1984, Sep-08, Volume: 66, Issue:10

    Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Menopause; Methotrexate; Tamoxifen; Time Factors

1984